Zenas BioPharma, Inc. (ZBIO)
NASDAQ: ZBIO · Real-Time Price · USD
31.80
+7.90 (33.05%)
At close: Oct 27, 2025, 4:00 PM EDT
31.50
-0.30 (-0.94%)
After-hours: Oct 27, 2025, 7:58 PM EDT

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023
Period Ending
Dec '24 Dec '23
Immune-based Therapies
5.00M
Log In
Immune-based Therapies Growth
-90.00%
Log In

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023
Period Ending
Dec '24 Dec '23
United States
5.00M
Log In
United States Growth
-90.00%
Log In